To understand whether combination antiretroviral therapy ( cART ) has been optimized , we asked whether @-drug protease inhibitor ( PI ) - based cART intensified with raltegravir and maraviroc and initiated during early infection would improve outcomes when compared with similarly applied @-drug PI-based cART .